whether MORE patients should get a statin for primary prevention of cardiovascular events
December 2008
You'll hear new debate about whether MORE patients should get a statin for primary prevention of cardiovascular events.
Statins have only been on the market since 1987.
They were initially approved just to lower cholesterol...without solid proof of beneficial outcomes.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote